Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.30 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11965231 | 0.82 | ESR2 (0.44) | APPCYP3A4CYP2C9CYP2D6CYP2C19 | |
| SCHEMBL11965811 | 0.82 | ALOX5AP (0.31) | — | |
| SCHEMBL11953548 | 0.81 | CYP3A4 (0.35) | APPCYP3A4CYP2C9CYP2D6CYP2C19 | |
| SCHEMBL11966363 | 0.79 | NOTUM (0.32) | — | |
| SCHEMBL11895211 | 0.78 | KDM1A (0.35) | APPCYP3A4CYP2C9CYP2D6CYP2C19 | |
| SCHEMBL28918828 | 0.78 | FFAR2 (0.38) | APPCYP3A4CYP2C9CYP2D6CYP2C19 | |
| SCHEMBL11965230 | 0.76 | TRPV3 (0.37) | APPCYP3A4CYP2C9CYP2D6CYP2C19 | |
| SCHEMBL11966369 | 0.76 | NOTUM (0.30) | — | |
| SCHEMBL10302852 | 0.74 | AKR1C3 (0.42) | — | |
| SCHEMBL30142433 | 0.73 | FPR2 (0.35) | APPCYP3A4CYP2C9RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120193577-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2012-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120193577-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | KIF23, MARK3, CCND3 | APP 1816/4885CYP3A4 2573/4885CYP2C9 2762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.